News

An interview with Daniel Williams, DO on Velocity’s PIVOT program and training the next generation of Principal Investigators

Very few physicians begin their careers with an eye on research. Moving into the role of Principal Investigator (PI) can be unexpectedly challenging, with demands that often take physicians by surprise. “Much of my experience with clinical research centered around reviewing journal articles for clinical practice,” explains Daniel Williams, DO, FAAEM, who transitioned from emergency … Read more

Could clinical trials be a safe healthcare space for the LGBTQ+ community?

By Stephanie Anderson, Chief of Staff Representation in clinical trials is crucial for equitable healthcare. Yet, the nature of clinical trial sites, which have historically been based in municipal centers where patient populations are highest, automatically excludes huge swathes of the population, such as those living in rural areas. These sites are also rarely positioned … Read more

Dr. Rosenstock is the Lead Investigator for Lilly’s ACHIEVE-1 Trial for Oral GLP-1, Orforglipron, Results Published in NEJM

Tremendous results! Julio Rosenstock, MD, recently authored and presented results for Lilly’s Phase 3 ACHIEVE-1 trial. The once-daily pill significantly reduced A1C (1.3-1.6%) and led to an average 16-pound weight loss. The results were presented by Dr. Rosenstock at the American Diabetes Association Scientific Sessions and published in The New England Journal of Medicine. “The … Read more

Velocity Joins Advarra’s Council for Responsible Use of AI in Clinical Trials as Founding Member

We’re proud to share that Velocity Clinical Research has joined Advarra’s newly launched Council for Responsible Use of AI in Clinical Trials as a founding member—alongside fellow industry leaders from Sanofi and Recursion. This cross-industry initiative will focus on setting standards, defining measurable outcomes, and guiding the ethical use of AI across the clinical trial … Read more

BioSpace Article: U.S. Uncertainty Creates Clinical Trial Leadership Opportunity for Europe

The U.S. clinical research landscape faces uncertainty. NIH grant cancellations, FDA staffing cuts, and regulatory uncertainty are creating real challenges for the industry’s traditional leader. Europe has an opportunity if it acts decisively. In his latest op-ed for BioSpace, Craig Koch examines why this moment matters for European clinical research. While the EEA’s share of … Read more

Velocity’s VISION Reaches More than $12.6 Million in Payments and 10,000 Randomizations

VISION has now contributed to more than 10,000 participant randomizations worldwide. Additionally, over $12.6 million in stipends have been paid through the VISION Engage mobile app, which is active in four countries and available in four languages. VISION continues to connect more people to clinical trials, enhance the participant experience, and reduce site burden. Learn … Read more

Henrik Watz, MD, PhD, Named Top COPD Scholar

Henrik Watz, MD, PhD, has been named a 2024 Top Scholar by ScholarGPS, ranked #34 globally among chronic obstructive pulmonary disease (COPD) researchers over the past five years, and recognized among the top 0.5% of all researchers worldwide. Over the past year, Dr. Watz has: Presented compelling real-world data at ATS 2025 on the long-term … Read more

Henrik Watz, MD, PhD, Presents Promising Asthma Trial Results at ATS 2025

Henrik Watz, MD, PhD, presented compelling real-world data at the American Thoracic Society Annual Meeting on the long-term impact of dupilumab therapy in patients with severe asthma. Participants in the ProVENT study experienced sustained improvements in lung function, asthma control, and quality of life. Notably, more than half achieved asthma remission within two years of … Read more